Much evidence suggests a pivotal role for NMDAR-mediated excitotoxicity in the pathogenesis of ALS (2, 3); for this reason we investigated the in vivo effect of the NMDA receptor antagonist REL-1017 on ALS onset and progression in the G93A SOD1 mouse. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.